Related Experiment Video
Updated: May 28, 2026

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
Published on: September 26, 2011
Mortality trends in the US Perinatal AIDS Collaborative Transmission Study (1986-2004)
Bill G Kapogiannis1, Minn M Soe, Steven R Nesheim
1Pediatric, Adolescent and Maternal AIDS Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 6100 Executive Blvd., Bethesda, MD 20892-7510, USA. kapogiannisb@mail.nih.gov
Highly active antiretroviral therapy (HAART) significantly reduced mortality in HIV-infected children. Survival rates improved dramatically across treatment eras, with HAART leading to a 94% 6-year survival probability for early recipients.
Area of Science:
- Pediatric Infectious Diseases
- Public Health
- Epidemiology
Background:
- Highly active antiretroviral therapy (HAART) has transformed outcomes for HIV-infected individuals.
- Evaluating the long-term impact of HAART on pediatric HIV mortality is crucial due to bimodal mortality patterns.
Purpose of the Study:
- To assess the temporal trends in mortality and survival among a prospective birth cohort of HIV-infected children.
- To evaluate the specific impact of HAART on reducing mortality and improving survival rates.
Main Methods:
- Prospective, multicenter birth cohort study (PACTS/HOPE) of HIV-exposed and infected infants (1985-2004).
- Mortality analysis stratified by treatment eras: no/monotherapy, mono-/dual-therapy, and HAART.
- Survival rates and mortality rates were calculated and compared across eras.
Main Results:
- Annual mortality rates decreased significantly from 18 to 0.8 deaths per 100 person-years from the no/monotherapy to the HAART era.
- 6-year survival rates improved from 57% to 91% across the eras; HAART recipients had a 94% 6-year survival probability.
- HAART was associated with a significant reduction in mortality (HR, 0.3; 95% CI, .08-.76), with opportunistic infections accounting for fewer deaths over time.
Conclusions:
- HAART implementation led to a significant decrease in annual mortality and a substantial prolongation of survival in US perinatal HIV-infected children.
- While OI-related deaths decreased, non-OI-associated deaths became proportionally more prominent.
- The findings underscore the profound positive impact of HAART on pediatric HIV outcomes.
Related Concept Videos
Amebiasis
Longitudinal Research
Retrovirus Life Cycles
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Sexually Transmitted Infections
Life Tables